Physician profile
Umar M Osman
NPI 1487882635
$19,277.00
in general payments reported to CMS, 2019-2025
43 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,974 · 2021: $921 · 2022: $360 · 2023: $265 · 2024: $384 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $6,654.35 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $2,143.50 | 2019-2024 | Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,704.49 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $934.27 | 2019-2025 | Jascayd, Spiriva Respimat, Stiolto Respimat |
| Pulmonx Corporation | $790.99 | 2019-2021 | |
| Boston Scientific Corporation | $753.63 | 2019 | |
| Bard Access Systems, INC. | $603.18 | 2019 | |
| Merck Sharp & Dohme LLC | $541.90 | 2019-2020 | |
| Olympus Corporation of The Americas | $450.67 | 2019 | |
| Insmed, INC. | $424.01 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $388.10 | 2019-2023 | Dupixent |
| Mallinckrodt Hospital Products INC. | $311.15 | 2020-2021 | |
| Grifols USA, LLC | $306.02 | 2019-2024 | Prolastin-C Liquid |
| Genentech USA, INC. | $301.13 | 2019-2021 | |
| United Therapeutics Corporation | $277.50 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umar Osman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.